// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Adult SLE: survivors from childhood onset

Anisur Rahman - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

End stage renal disease

N/A

Self-management for osteoarthritis: where have we ESCAPEd to?

Mike Hurley - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The current evidence for nurse-led care in people with inflammatory arthritis

Mwidimi Ndosi - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Getting here, going where? Things I wish I had known…

Iain McInnes - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dietary components influencing inflammation

Phillip Calder - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prostaglandin

Chronic musculoskeletal pain and the pitfalls of assuming fibromyalgia

Frank McKenna - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Irritable Bowel Syndrome

Sandolase

MSK manifestations of diabetes

Ed Jude - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

What do Rheumatologists need to know about Sport and Exercise Medicine?

Julia Newton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Is there an evidence basis to the use of glucocorticoids in GCA?

Chetan Mukhtyar - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Glucocorticoid

Non-pharmacological management of vertebral fractures

Emma M Clark - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Implementing a structured protocol for Biologics Treatment Reduction by Interval Management (B-TRIM)

Emily Rose-Parfitt - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

What do patients think about the idea of biologic dose reduction and what information do patients need to make decisions about dose reduction?

Andrew Haig-Ferguson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient activation: what is it?

Bethan Jones - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

SLE: science in paediatric and adolescent patients

Michael Beresford - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The long-term complications of non-fatal rheumatoid arthritis

Peter Taylor - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Sandolase

Vocational rehabilitation and the armed services

John Etherington - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Understanding the heterogeneity of interstitial lung disease

Harsha Gunawardena - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

N/A

Evaluation and management of skin fibrosis in systemic sclerosis

Christopher Denton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Scleroderma

Mycophenolate mofetil

Variation in access to foot care in people with rheumatoid arthritis

Michael R Backhouse - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Recruitment, follow-up and ensuring good quality data in clinical research

Zoe Plummer - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved